Laboratory Corporation of America Holdings
Compositions and Methods for Identifying Subjects Who May Benefit From Treatment With Therapeutic Agents
Last updated:
Abstract:
Disclosed herein are compositions and methods for the identification of subjects who are likely to benefit from use of a therapeutic agent. The present invention utilizes the specificity of therapeutic monoclonal antibodies for a single epitope to determine whether a therapeutic monoclonal antibody interacts with biological material in/from a patient.
Status:
Application
Type:
Utility
Filling date:
27 Mar 2019
Issue date:
3 Oct 2019